Spero Therapeutics
SPRO
#9395
Rank
$52.07 M
Marketcap
$0.96
Share price
-4.30%
Change (1 day)
-29.25%
Change (1 year)

Spero Therapeutics (SPRO) - Cash on Hand

Cash on Hand as of September 2024 : $76.29 Million USD

According to Spero Therapeutics's latest financial reports the company has $76.29 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Spero Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$76.33 M-30.04%
2022-12-31$0.10 B-25.47%
2021-12-31$0.14 B15.36%
2020-12-31$0.12 B54.68%
2019-12-31$82.04 M-28.93%
2018-12-31$0.11 B32.26%
2017-12-31$87.28 M746.22%
2016-12-31$10.31 M81.25%
2015-12-31$5.69 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$48.66 M-36.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.70 B 17,860.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.78 B 2,239.76%๐Ÿ‡จ๐Ÿ‡ฆ Canada